Electrophysiologic studies in patients with bundle branch block

Insights

A prolonged infranodal conduction time (H-Q) in patients with chronic bundle branch block predicts atrioventricular block. Prophylactic pacing does not improve outcomes, but electrophysiologic studies are vital for syncope evaluation.

Area of Science:

  • Cardiology
  • Electrophysiology

Background:

  • Chronic bundle branch block (BBB) poses risks for atrioventricular (AV) block.
  • Predictive markers for AV block progression in BBB are crucial for patient management.

Purpose of the Study:

  • To investigate the predictive value of infranodal conduction time (H-Q interval) for AV block in chronic BBB patients.
  • To evaluate the efficacy of prophylactic pacemaker insertion and electrophysiologic studies in managing BBB complications.

Main Methods:

  • Electrophysiologic studies were performed on 401 chronic BBB patients, with a mean follow-up of 30 months.
  • Infranodal conduction time (H-Q) was measured, and patients were categorized based on H-Q interval duration.
  • Subgroups underwent prophylactic pacing or ventricular stimulation studies.

Main Results:

  • Patients with H-Q ≥ 70 ms showed a significantly higher incidence of AV block (12%) compared to those with H-Q < 70 ms (3.5%).
  • An H-Q interval ≥ 100 ms was associated with a 25% incidence of AV block.
  • Prophylactic pacing did not significantly alter symptom relief or survival rates.
  • Ventricular tachycardia was induced in 14 of 25 syncope patients undergoing ventricular stimulation.

Conclusions:

  • A markedly prolonged H-Q interval (≥ 100 ms) is a valuable predictor of spontaneous AV block in chronic BBB.
  • Prophylactic pacing offers no benefit for symptom relief or survival in this patient cohort.
  • Electrophysiologic and ventricular stimulation studies are indicated for BBB patients experiencing syncope.

Related Concept Videos

Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
Electrophysiology of Normal Cardiac Rhythm01:19

Electrophysiology of Normal Cardiac Rhythm

The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase of...
Dysrhythmias IV: Characteristics of Bradyarrhythmias01:18

Dysrhythmias IV: Characteristics of Bradyarrhythmias

Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...